About Chugai
Chugai’s mission is
to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Nov 22, 2023 Chugai Launches Phesgo Subcutaneous Combination for the Treatment of HER2-Positive Breast and Colorectal Cancer
- Nov 21, 2023 Organizational and Personnel Changes
- Nov 16, 2023 Chugai Receives the Best IR Award, the Greatest IR Improvement Premium Companies, and the Best Continual IR Efforts Premium Companies
- Nov 09, 2023 The Launch of Chugai’s New TV Commercial Featuring Tori Matsuzaka “Innovation Lab / AI-leveraging Drug Discovery”
- Nov 07, 2023 Non-Clinical Research Results of Chugai’s NXT007 Published in Journal of Thrombosis and Haemostasis
